Cargando…
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
Twenty-one patients with poor prognosis nonseminomatous germ cell tumours (six with extreme burden disease at presentation in whom partial remission had been achieved with initial induction therapy, and 15 with recurrent disease after induction therapy) were treated with high-dose chemotherapy and a...
Autores principales: | Barnett, M. J., Coppin, C. M., Murray, N., Nevill, T. J., Reece, D. E., Klingemann, H. G., Shepherd, J. D., Nantel, S. H., Sutherland, H. J., Phillips, G. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968411/ https://www.ncbi.nlm.nih.gov/pubmed/8394733 |
Ejemplares similares
-
Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour
por: O'Leary, C. G., et al.
Publicado: (2016) -
An orthotopic xenograft model of human nonseminomatous germ cell tumour
por: Douglas, M L, et al.
Publicado: (2001) -
Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
por: Jay, Alexander P.M., et al.
Publicado: (2021) -
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
por: Bokemeyer, C, et al.
Publicado: (2003) -
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
por: Bilen, Mehmet Asim, et al.
Publicado: (2016)